Adaptive control demonstrates robustness in tumor suppression and toxicity management during chemotherapy dosing, addressing patient dynamics.
This paper proposes a delay-aware adaptive control framework for individualized chemotherapy dosing based on online critic learning. The approach explicitly compensates for pharmacokinetic and pharmacodynamic delays while adapting to patient-specific uncertainties. An online critic network estimates the value function to guide real-time dose adjustments. Simulation results on diverse patient profiles demonstrate effective tumor suppression and toxicity control, highlighting the robustness of the proposed scheme to variations in delay and patient dynamics.
No takes yet. Share an insight, caveat, or question.
Rahimi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: